{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:56:49Z","timestamp":1790909809236,"version":"4.1.0"},"reference-count":293,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Kinetoplastids are protozoa that possess a unique organelle called a kinetoplast. These include the parasites Trypanosoma cruzi, T. brucei and related African trypanosomes, and Leishmania spp. These parasites cause a variety of neglected tropical diseases in humans and livestock, with devastating consequences. In the absence of any vaccine, pharmaceutical interventions are the mainstay of control, but these have historically been underfunded, fragmented, and inadequately aligned with the complex zoonotic and ecological realities of the parasites\u2019 transmission dynamics. In this review, the landscape of current and emerging drugs for treating leishmaniasis, Chagas disease, and African trypanosomiasis is critically evaluated across both veterinary and human contexts. It examines the challenges of legacy compounds, the pharmacological shortcomings in multi-host, multi-tropic and multi-stage disease systems, and the gaps in veterinary therapeutics, specifically for African animal trypanosomiasis and canine leishmaniasis but also the animal reservoir of T. cruzi. Emphasis is placed on pharmacokinetic divergence between species, the accompanying risks with the use of off-label human drugs in animals, and the ecological effects of environmental drug exposure. We propose a far-reaching One Health framework for pharmaceutical research and development, promoting dual-indication co-development, ecological pharmacology, regulatory harmonisation, and integrated delivery systems. In this context, we argue that the drug development pipeline must be rationalised as a transdisciplinary and ecologically embedded process, able to interrupt parasite transmission to human, animal, and vector interfaces. Our findings reveal that we can bridge age-old therapeutic gaps, advance towards sustainable control, and eventually eliminate the neglected diseases caused by kinetoplastid protozoan parasites by aligning pharmaceutical innovation with One Health principles. This article aims to promote future research and development of innovative drugs that are sustainable under the One Health framework.<\/jats:p>","DOI":"10.3390\/ph18091415","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:53:42Z","timestamp":1758300822000},"page":"1415","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interventions for Neglected Diseases Caused by Kinetoplastid Parasites: A One Health Approach to Drug Discovery, Development, and Deployment"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4072-9800","authenticated-orcid":false,"given":"Godwin U.","family":"Ebiloma","sequence":"first","affiliation":[{"name":"School of Science, Engineering & Environment, University of Salford, Manchester M5 4NT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8133-0414","authenticated-orcid":false,"given":"Amani","family":"Alhejeli","sequence":"additional","affiliation":[{"name":"Biology Department, Darb University College, Jazan 45142, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-1827","authenticated-orcid":false,"given":"Harry P.","family":"de Koning","sequence":"additional","affiliation":[{"name":"School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40475-023-00304-w","article-title":"Human African Trypanosomiasis (Sleeping Sickness)\u2014Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention","volume":"10","author":"Bongomin","year":"2023","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-4894(03)00067-5","article-title":"Trypanosoma Vivax: Mechanical Transmission in Cattle by One of the Most Common African Tabanids, Atylotus Agrestis","volume":"103","author":"Desquesnes","year":"2003","journal-title":"Exp. Parasitol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Desquesnes, M., Dargantes, A., Lai, D.H., Lun, Z.R., Holzmuller, P., and Jittapalapong, S. (2013). Trypanosoma evansi and Surra: A Review and Perspectives on Transmission, Epidemiology and Control, Impact, and Zoonotic Aspects. Biomed. Res. Int., 2013.","DOI":"10.1155\/2013\/321237"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100533","DOI":"10.1016\/j.ijpddr.2024.100533","article-title":"Drug Resistance in Animal Trypanosomiases: Epidemiology, Mechanisms and Control Strategies","volume":"25","author":"Ungogo","year":"2024","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00023-19","DOI":"10.1128\/CMR.00023-19","article-title":"Chagas Disease in the United States: A Public Health Approach","volume":"33","author":"Bern","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas Disease: A Latin American Health Problem Becoming a World Health Problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Trop."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2017.05.001","article-title":"Chagas Disease in Europe: A Review for the Internist in the Globalized World","volume":"43","author":"Antinori","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s11259-023-10171-5","article-title":"Is Leishmaniasis the New Emerging Zoonosis in the World?","volume":"47","author":"Llobat","year":"2023","journal-title":"Vet. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Maia, C., Concei\u00e7\u00e3o, C., Pereira, A., Rocha, R., Ortu\u00f1o, M., Mu\u00f1ozid, C., Jumakanova, Z., P\u00e9rez-Cutillas, P., \u00d6zbel, Y., and T\u00f6z, S. (2023). The Estimated Distribution of Autochthonous Leishmaniasis by Leishmania infantum in Europe in 2005\u20132020. PLoS Negl. Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011497"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wilson, A.L., Courtenay, O., Kelly-Hope, L.A., Scott, T.W., Takken, W., Torr, S.J., and Lindsay, S.W. (2020). The Importance of Vector Control for the Control and Elimination of Vector-Borne Diseases. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0007831"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ventura-Garcia, L., Roura, M., Pell, C., Posada, E., Gasc\u00f3n, J., Aldasoro, E., Mu\u00f1oz, J., and Pool, R. (2013). Socio-Cultural Aspects of Chagas Disease: A Systematic Review of Qualitative Research. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002410"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and Economic Burden of Human Leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_14","first-page":"135","article-title":"Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review","volume":"12","author":"Grifferty","year":"2021","journal-title":"Res. Rep. Trop. Med."},{"key":"ref_15","unstructured":"World Health Organization (2025, August 04). Chagas Disease (Also Known as American Trypanosomiasis), Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis)."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"de Koning, H.P. (2020). The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History. Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5010014"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijpddr.2018.09.006","article-title":"Challenges in Drug Discovery Targeting TriTryp Diseases with an Emphasis on Leishmaniasis","volume":"8","author":"Ferreira","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100071","DOI":"10.1016\/j.amolm.2025.100071","article-title":"Kinetoplastid Diseases: Insights into the Mechanisms of Drug Action and Resistance for Novel Drug Discovery","volume":"5","author":"Tauheed","year":"2025","journal-title":"Asp. Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e000709","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why Miltefosine\u2014A Life-Saving Drug for Leishmaniasis\u2014Is Unavailable to People Who Need It the Most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ Glob. Health"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Das, A.M., Chitnis, N., Burri, C., Paris, D.H., Patel, S., Spencer, S.E.F., Miaka, E.M., and Casta\u00f1o, M.S. (2021). Modelling the Impact of Fexinidazole Use on Human African Trypanosomiasis (HAT) Transmission in the Democratic Republic of the Congo. PLoS Negl. Trop. Dis., 15.","DOI":"10.1101\/2021.06.09.21258601"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1016\/S2214-109X(25)00068-3","article-title":"Fexinidazole for Human African Trypanosomiasis: The Challenge of Accessibility","volume":"13","author":"Miaka","year":"2025","journal-title":"Lancet Glob. Health"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Bravo, A., Cirignoli, S., Wehrendt, D., Schijman, A., Le\u00f3n, C.M., Flores-Chaves, M., Nieto, J., Kieran, T.J., Abril, M., and Guhl, F. (2024). Zoonotic Cycle of American Trypanosomiasis in an Endemic Region of the Argentine Chaco, Factors That Influenced a Paradigm Shift. Insects, 15.","DOI":"10.3390\/insects15070471"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ilar\/ilx020","article-title":"Toward an Ecological Framework for Assessing Reservoirs of Vector-Borne Pathogens: Wildlife Reservoirs of Trypanosoma cruzi across the Southern United States","volume":"58","author":"Hodo","year":"2017","journal-title":"ILAR J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1590\/s1678-9946202365024","article-title":"Can Domestic Dogs Be Considered a Good Reservoir of Leishmania (L.) infantum chagasi in an Endemic Area of Nonulcerated Cutaneous Leishmaniasis in Southern Honduras?","volume":"65","author":"Segura","year":"2023","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_25","first-page":"717","article-title":"Ecological Habitat of Small Mammals as Reservoirs of Leishmania spp. in the Endemic Foci of Cutaneous Leishmaniasis, the North Iran","volume":"9","author":"Oranjin","year":"2025","journal-title":"J. Zoonotic Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The Animal Trypanosomiases and Their Chemotherapy: A Review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Garlapati, R., Iniguez, E., Serafim, T.D., Mishra, P.K., Rooj, B., Sinha, B., Valenzuela, J.G., Srikantiah, S., Bern, C., and Kamhawi, S. (2021). Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.641632"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"R517","DOI":"10.1016\/j.cub.2024.04.025","article-title":"One Health","volume":"34","author":"Bertram","year":"2024","journal-title":"Curr. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hong, A., Zampieri, R.A., Shaw, J.J., Floeter-Winter, L.M., and Laranjeira-Silva, M.F. (2020). One Health Approach to Leishmaniases: Understanding the Disease Dynamics through Diagnostic Tools. Pathogens, 9.","DOI":"10.3390\/pathogens9100809"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Khan, Y., Lin, I.-C., Khan, S., Kanwal, M., Wajid, A., Khan, A., Noor, F., Almajwal, A.M., Chen, C.-C., and Qadeer, A. (2025). Knowledge, Attitudes, and Practices toward Leishmaniasis and One Health: A Cross-Sectional Study among Medical and Veterinary Professionals. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1515370"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106804","DOI":"10.1016\/j.actatropica.2022.106804","article-title":"Does a One Health Approach to Human African Trypanosomiasis Control Hasten Elimination? A Stochastic Compartmental Modeling Approach","volume":"240","author":"Meisner","year":"2023","journal-title":"Acta Trop."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1073\/pnas.1305404110","article-title":"Single Point Mutations in ATP Synthase Compensate for Mitochondrial Genome Loss in Trypanosomes","volume":"110","author":"Dean","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: Related Protozoan Pathogens, Different Diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nouvellet, P., Dumonteil, E., and Gourbi\u00e8re, S. (2013). The Improbable Transmission of Trypanosoma cruzi to Human: The Missing Link in the Dynamics and Control of Chagas Disease. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002505"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Babuadze, G., Alvar, J., Argaw, D., de Koning, H.P., Iosava, M., Kekelidze, M., Tsertsvadze, N., Tsereteli, D., Chakhunashvili, G., and Mamatsashvili, T. (2014). Epidemiology of Visceral Leishmaniasis in Georgia. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002725"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40249-017-0375-2","article-title":"Addressing Vulnerability, Building Resilience: Community-Based Adaptation to Vector-Borne Diseases in the Context of Global Change","volume":"6","author":"Bardosh","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1007\/s00436-022-07594-5","article-title":"Isolation, Typing, and Drug Susceptibility of Leishmania (Leishmania) infantum Isolates from Dogs of the Municipality of Embu Das Artes, an Endemic Region for Canine Leishmaniasis in Brazil","volume":"121","author":"Ferreira","year":"2022","journal-title":"Parasitol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s13071-018-3067-2","article-title":"Trypanosoma cruzi Transmission in the Wild and Its Most Important Reservoir Hosts in Brazil","volume":"11","author":"Jansen","year":"2018","journal-title":"Parasit. Vectors"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13071-025-06849-1","article-title":"Association between Landscape Transformation and the Chagas Disease Vector Dynamics in a Rural Area with Continuous Surveillance and Control","volume":"18","author":"Sandon","year":"2025","journal-title":"Parasit. Vectors"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vetpar.2006.02.026","article-title":"High Prevalence of Trypanosoma brucei gambiense Group 1 in Pigs from the Fontem Sleeping Sickness Focus in Cameroon","volume":"139","author":"Simo","year":"2006","journal-title":"Vet. Parasitol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kasozi, K.I., Zirintunda, G., Ssempijja, F., Buyinza, B., Alzahrani, K.J., Matama, K., Nakimbugwe, H.N., Alkazmi, L., Onanyang, D., and Bogere, P. (2021). Epidemiology of Trypanosomiasis in Wildlife\u2014Implications for Humans at the Wildlife Interface in Africa. Front. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.621699"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stone, C.M., and Chitnis, N. (2015). Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control. PLoS Comput. Biol., 11.","DOI":"10.1371\/journal.pcbi.1004514"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0031182004005876","article-title":"Mixed Infections of Trypanosomes in Tsetse and Pigs and Their Epidemiological Significance in a Sleeping Sickness Focus of C\u00f4te d\u2019Ivoire","volume":"129","author":"Jamonneau","year":"2004","journal-title":"Parasitology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vetpar.2015.05.003","article-title":"Spread of Leishmania infantum in Europe with Dog Travelling","volume":"213","author":"Maia","year":"2015","journal-title":"Vet. Parasitol."},{"key":"ref_45","first-page":"100971","article-title":"A Climatic Suitability Indicator to Support Leishmania infantum Surveillance in Europe: A Modelling Study","volume":"43","author":"Carvalho","year":"2024","journal-title":"Lancet Reg. Health\u2013Eur."},{"key":"ref_46","first-page":"100768","article-title":"Chagas Disease in the United States: A Call for Increased Investment and Collaborative Research","volume":"34","author":"Higuita","year":"2024","journal-title":"Lancet Reg. Health\u2013Am."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1021\/jm0612867","article-title":"Synthesis and in Vitro Antiprotozoal Activities of Dicationic 3,5-Diphenylisoxazoles","volume":"50","author":"Patrick","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1473-3099(22)00660-0","article-title":"Efficacy and Safety of Acoziborole in Patients with Human African Trypanosomiasis Caused by Trypanosoma brucei gambiense: A Multicentre, Open-Label, Single-Arm, Phase 2\/3 Trial","volume":"23","author":"Kalonji","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/acsinfecdis.4c00472","article-title":"Discovery and Development of an Advanced Lead for the Treatment of African Trypanosomiasis","volume":"11","author":"Ilbeigi","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Pandey, P., Garg, A., Garg, S., Singh, V., Rai, G., and Mishra, N. (2024). Role of Controlled Release in Veterinary Formulations. Novel Carrier Systems for Targeted and Controlled Drug Delivery, Springer Science + Business Media.","DOI":"10.1007\/978-981-97-4970-6_10"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11270-022-05744-0","article-title":"Effects of Avermectins on the Environment Based on Its Toxicity to Plants and Soil Invertebrates\u2014A Review","volume":"233","year":"2022","journal-title":"Water Air Soil Pollut."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"117299","DOI":"10.1016\/j.ecoenv.2024.117299","article-title":"Environmental Contamination by Veterinary Medicinal Products and Their Implications in the Conservation of the Endangered Pyrenean Capercaillie (Tetrao Urogallus Aquitanicus)","volume":"288","author":"Ewbank","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Van den Kerkhof, M., Sterckx, Y.G.J., Leprohon, P., Maes, L., and Caljon, G. (2020). Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites. Microorganisms, 8.","DOI":"10.3390\/microorganisms8060950"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.20506\/rst.27.2.1803","article-title":"Leishmaniasis Emergence and Climate Change","volume":"27","author":"Ready","year":"2008","journal-title":"OIE Rev. Sci. Tech."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Matsumoto, P.S.S., Hiramoto, R.M., Pereira, V.B.R., Camprigher, V.M., Taniguchi, H.H., De Raeffray Barbosa, J.E., De Barros Cortez, L.R.P., Da Silva Fonseca, E., Guimar\u00e3es, R.B., and Tolezano, J.E. (2021). Impact of the Dog Population and Household Environment for the Maintenance of Natural Foci of Leishmania infantum Transmission to Human and Animal Hosts in Endemic Areas for Visceral Leishmaniasis in Sao Paulo State, Brazil. PLoS ONE, 16.","DOI":"10.1101\/2021.05.18.21257380"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Costa-Da-silva, A.C., Nascimento, D.d.O., Ferreira, J.R.M., Guimar\u00e3es-Pinto, K., Freire-De-lima, L., Morrot, A., Decote-Ricardo, D., Filardy, A.A., and Freire-De-lima, C.G. (2022). Immune Responses in Leishmaniases: An Overview. Trop. Med. Infect. Dis., 7.","DOI":"10.3390\/tropicalmed7040054"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ponte-Sucre, A., Gamarro, F., Dujardin, J.C., Barrett, M.P., L\u00f3pez-V\u00e9lez, R., Garc\u00eda-Hern\u00e1ndez, R., Pountain, A.W., Mwenechanya, R., and Papadopoulou, B. (2017). Drug Resistance and Treatment Failure in Leishmaniasis: A 21st Century Challenge. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006052"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zhang, H., Yan, R., Liu, Y., Yu, M., He, Z., Xiao, J., Li, K., Liu, G., Ning, Q., and Li, Y. (2025). Progress in Antileishmanial Drugs: Mechanisms, Challenges, and Prospects. PLoS Negl. Trop. Dis., 19.","DOI":"10.1371\/journal.pntd.0012735"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e12613","DOI":"10.7554\/eLife.12613","article-title":"Evolutionary Genomics of Epidemic Visceral Leishmaniasis in the Indian Subcontinent","volume":"5","author":"Imamura","year":"2016","journal-title":"eLife"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/cid\/ciaa1236","article-title":"Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani","volume":"72","author":"Potvin","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Haldar, A.K., Sen, P., and Roy, S. (2011). Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions. Mol. Biol. Int., 2011.","DOI":"10.4061\/2011\/571242"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","article-title":"Current Challenges in Treatment Options for Visceral Leishmaniasis in India: A Public Health Perspective","volume":"5","author":"Singh","year":"2016","journal-title":"Infect. Dis. Poverty"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-194809000-00003","article-title":"The Pharmacology, Mode of Action and Therapeutic Potentialities of Stilbamidine, Pentamidine, Propamidine and Other Aromatic Diamidines\u2014A Review","volume":"27","author":"Schoenbach","year":"1948","journal-title":"Medicine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0974-777X.62887","article-title":"Drug Resistance in Leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"105988","DOI":"10.1016\/j.actatropica.2021.105988","article-title":"An Appraisal of the Scientific Current Situation and New Perspectives in the Treatment of Cutaneous Leishmaniasis","volume":"221","author":"Cid","year":"2021","journal-title":"Acta Trop."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of Meglumine Antimoniate and Pentamidine for Peruvian Cutaneous Leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/clind\/16.3.417","article-title":"Evaluation of Pentamidine for the Treatment of Cutaneous Leishmaniasis in Colombia","volume":"16","author":"Grogl","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e3021","DOI":"10.1002\/jmr.3021","article-title":"Drug Repositioning to Discover Novel Ornithine Decarboxylase Inhibitors against Visceral Leishmaniasis","volume":"36","author":"Sheikh","year":"2023","journal-title":"J. Mol. Recognit."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Basselin, M., Lawrence, F., and Robert-Gero, M. (1996). Pentamidine Uptake in Leishmania Donovani and Leishmania Amazonensis Promastigotes and Axenic Amastigotes. Biochem. J., 315.","DOI":"10.1042\/bj3150631"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Tiwari, N., Kumar, A., Singh, A.K., Bajpai, S., Agrahari, A.K., Kishore, D., Tiwari, V.K., and Singh, R.K. (2019). Leishmaniasis Control: Limitations of Current Drugs and Prospects of Natural Products. Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases, Elsevier.","DOI":"10.1016\/B978-0-12-815723-7.00008-0"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/bj2840463","article-title":"Ca2+ Transport by Digitonin-Permeabilized Leishmania Donovani. Effects of Ca2+, Pentamidine and WR-6026 on Mitochondrial Membrane Potential in Situ","volume":"284","author":"Vercesi","year":"1992","journal-title":"Biochem. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00034983.1982.11687502","article-title":"Effect of Pentamidine Isethionate on the Ultrastructure and Morphology of Leishmania Mexicana Amazonensis in Vitro","volume":"76","author":"Croft","year":"1982","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.46.12.3731-3738.2002","article-title":"Resistance to Pentamidine in Leishmania mexicana Involves Exclusion of the Drug from the Mitochondrion","volume":"46","author":"Basselin","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","first-page":"586","article-title":"Uptake of Pentamidine in Trypanosoma Brucei Brucei Is Mediated by Three Distinct Transporters: Implications for Cross-Resistance with Arsenicals","volume":"59","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma brucei Aquaglyceroporin 2 Is a High-Affinity Transporter for Pentamidine and Melaminophenyl Arsenic Drugs and the Main Genetic Determinant of Resistance to These Drugs","volume":"69","author":"Munday","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","article-title":"Paromomycin","volume":"103","author":"Davidson","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Webster, C.M., and Shepherd, M. (2023). A Mini-Review: Environmental and Metabolic Factors Affecting Aminoglycoside Efficacy. World J. Microbiol. Biotechnol., 39.","DOI":"10.1007\/s11274-022-03445-8"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-017-01664-4","article-title":"Atomic Resolution Snapshot of Leishmania Ribosome Inhibition by the Aminoglycoside Paromomycin","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/excr.1997.3500","article-title":"In Vivo Interference of Paromomycin with Mitochondrial Activity of Leishmania","volume":"232","author":"Maarouf","year":"1997","journal-title":"Exp. Cell Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40261-016-0481-0","article-title":"Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme","volume":"37","author":"Kimutai","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.19-0179","article-title":"Effectiveness of Single-Dose Liposomal Amphotericin b in Visceral Leishmaniasis in Bihar","volume":"101","author":"Sundar","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e70002","DOI":"10.1111\/pim.70002","article-title":"Solid Lipid Nanoparticles Encapsulated with Paromomycin: An Effective Oral Formulation Against Leishmania major in Mouse Model","volume":"47","author":"Rodrigues","year":"2025","journal-title":"Parasit. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00249-014-0983-8","article-title":"Recent Progress in the Study of the Interactions of Amphotericin B with Cholesterol and Ergosterol in Lipid Environments","volume":"43","year":"2014","journal-title":"Eur. Biophys. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0005-2736(82)90103-1","article-title":"Equilibrium Binding of Amphotericin B and Its Methyl Ester and Borate Complex to Sterols","volume":"685","author":"Readio","year":"1982","journal-title":"BBA\u2014Biomembr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0014-5793(02)03009-0","article-title":"Polyene Antibiotic Amphotericin B in Monomolecular Layers: Spectrophotometric and Scanning Force Microscopic Analysis","volume":"524","author":"Gruszecki","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"106661","DOI":"10.1016\/j.actatropica.2022.106661","article-title":"Amphotericin B: A Drug of Choice for Visceral Leishmaniasis","volume":"235","author":"Kumari","year":"2022","journal-title":"Acta Trop."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(13)70118-9","article-title":"Efficacy and Safety of Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in a Rural Public Hospital in Bangladesh: A Feasibility Study","volume":"2","author":"Mondal","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Wijnant, G.J., Dumetz, F., Dirkx, L., Bult\u00e9, D., Cuypers, B., Van Bocxlaer, K., and Hendrickx, S. (2022). Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Front. Trop. Dis., 3.","DOI":"10.3389\/fitd.2022.837460"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Fr\u00e9zard, F., Aguiar, M.M.G., Ferreira, L.A.M., Ramos, G.S., Santos, T.T., Borges, G.S.M., Vallejos, V.M.R., and De Morais, H.L.O. (2023). Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010099"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The Activity of Alkyl Phosphorylcholines and Related Derivatives against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.trstmh.2006.03.009","article-title":"Miltefosine\u2014Discovery of the Antileishmanial Activity of Phospholipid Derivatives","volume":"100","author":"Croft","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.trstmh.2006.02.011","article-title":"Oral Miltefosine for the Treatment of Indian Visceral Leishmaniasis","volume":"100","author":"Sundar","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbamem.2004.01.010","article-title":"Hexadecylphosphocholine Interaction with Lipid Monolayers","volume":"1661","author":"Rakotomanga","year":"2004","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpddr.2013.11.002","article-title":"Untargeted Metabolomic Analysis of Miltefosine Action in Leishmania infantum Reveals Changes to the Internal Lipid Metabolism","volume":"4","author":"Vincent","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e02095-17","DOI":"10.1128\/AAC.02095-17","article-title":"Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine","volume":"62","author":"Armitage","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Benaim, G., and Paniz-Mondolfi, A. (2024). Unmasking the Mechanism behind Miltefosine: Revealing the Disruption of Intracellular Ca2+ Homeostasis as a Rational Therapeutic Target in Leishmaniasis and Chagas Disease. Biomolecules, 14.","DOI":"10.20944\/preprints202402.1176.v1"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine Promotes IFN-\u03b3-Dominated Anti-Leishmanial Immune Response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: A Review of Its Pharmacology and Therapeutic Efficacy in the Treatment of Leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/138920009787846332","article-title":"Cellular Transport and Lipid Interactions of Miltefosine","volume":"10","author":"Barratt","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid Translocation and Miltefosine Potency Require Both L. donovani Miltefosine Transporter and the New Protein LdRos3 in Leishmania Parasites","volume":"281","author":"Castanys","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Coelho, A.C., Boisvert, S., Mukherjee, A., Leprohon, P., Corbeil, J., and Ouellette, M. (2012). Multiple Mutations in Heterogeneous Miltefosine-Resistant Leishmania Major Population as Determined by Whole Genome Sequencing. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001512"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02723096","article-title":"Miltefosine: An Oral Drug for Visceral Leishmaniasis","volume":"71","author":"Prasad","year":"2004","journal-title":"Indian J. Pediatr."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ramesh, V., Singh, R., Avishek, K., Verma, A., Deep, D.K., Verma, S., and Salotra, P. (2015). Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-Azar Dermal Leishmaniasis (PKDL) in India. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0004289"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Pijpers, J., Den Boer, M.L., Essink, D.R., and Ritmeijer, K. (2019). The Safety and Efficacy of Miltefosine in the Long-Term Treatment of Post-Kala-Azar Dermal Leishmaniasis in South Asia\u2014A Review and Meta-Analysis. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007173"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Astman, N., Arbel, C., Katz, O., Barzilai, A., Solomon, M., and Schwartz, E. (2024). Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9090218"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mrgentox.2016.06.007","article-title":"The Antileishmanial Drug Miltefosine (Impavido\u00ae) Causes Oxidation of DNA Bases, Apoptosis, and Necrosis in Mammalian Cells","volume":"806","author":"Soares","year":"2016","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13071-019-3323-0","article-title":"Use of Miltefosine to Treat Canine Visceral Leishmaniasis Caused by Leishmania Infantum in Brazil","volume":"12","author":"Avino","year":"2019","journal-title":"Parasit. Vectors"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Ribeiro, R.R., Michalick, M.S.M., Da Silva, M.E., Dos Santos, C.C.P., Fr\u00e9zard, F.J.G., and Da Silva, S.M. (2018). Canine Leishmaniasis: An Overview of the Current Status and Strategies for Control. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/3296893"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","article-title":"Long-Term Follow-up of Dogs with Leishmaniosis Treated with Meglumine Antimoniate plus Allopurinol versus Miltefosine plus Allopurinol","volume":"8","author":"Manna","year":"2015","journal-title":"Parasit. Vectors"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"119re1","DOI":"10.1126\/scitranslmed.3003326","article-title":"The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis","volume":"4","author":"Wyllie","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1515\/pac-2018-1102","article-title":"Current and Promising Novel Drug Candidates against Visceral Leishmaniasis","volume":"91","author":"Reguera","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"122505","DOI":"10.1016\/j.ijpharm.2022.122505","article-title":"A New Oral Self-Emulsifying Drug Delivery System Improves the Antileishmania Efficacy of Fexinidazole in Vivo","volume":"631","author":"Antunes","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical Candidate for the Treatment of Visceral Leishmaniasis That Acts through Proteasome Inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_116","unstructured":"DNDi (2025, September 03). Visceral Leishmaniasis: LXE408 Novartis for VL. Available online: https:\/\/dndi.org\/research-development\/portfolio\/lxe408-novartis-visceral-leishmaniasis\/?utm_source=chatgpt.com."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"16159","DOI":"10.1021\/acs.jmedchem.1c01437","article-title":"DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis","volume":"64","author":"Mowbray","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_118","unstructured":"DNDi (2025, September 03). New Hope for Novel Drugs for Leishmaniasis: Update of DNDi\u2019s Leishmaniasis R&D Pipeline. Available online: https:\/\/dndi.org\/wp-content\/uploads\/2017\/05\/DNDi_LeishmaniasisPipeline_2017.pdf?utm_source=chatgpt.com."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e00829-19","DOI":"10.1128\/AAC.00829-19","article-title":"Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis","volume":"63","author":"Wijnant","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Estrada, C., P\u00e9rez-Pertejo, Y., Dom\u00ednguez-Asenjo, B., Holanda, V.N., Murugesan, S., Mart\u00ednez-Valladares, M., Bala\u00f1a-Fouce, R., and Reguera, R.M. (2023). Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates. Biomolecules, 13.","DOI":"10.3390\/biom13040637"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"eadh9902","DOI":"10.1126\/scitranslmed.adh9902","article-title":"DNDI-6174 Is a Preclinical Candidate for Visceral Leishmaniasis That Targets the Cytochrome Bc1","volume":"15","author":"Braillard","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_122","first-page":"240","article-title":"Anti-Proliferative and Apoptosis Induction Activities of Curcumin on Leishmania major","volume":"53","author":"Elamin","year":"2021","journal-title":"Rev. Argent. Microbiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ejmech.2009.11.035","article-title":"Curcuminoid Analogs with Potent Activity against Trypanosoma and Leishmania Species","volume":"45","author":"Changtam","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Alotaibi, A., Ebiloma, G.U., Williams, R., Alfayez, I.A., Natto, M.J., Alenezi, S., Siheri, W., AlQarni, M., Igoli, J.O., and Fearnley, J. (2021). Activity of Compounds from Temperate Propolis against Trypanosoma brucei and Leishmania mexicana. Molecules, 26.","DOI":"10.3390\/molecules26133912"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/ptr.6383","article-title":"Flavonoids as Efficient Scaffolds: Recent Trends for Malaria, Leishmaniasis, Chagas Disease, and Dengue","volume":"33","author":"Boniface","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jac\/dkn053","article-title":"Quercetin Interferes with Iron Metabolism in Leishmania donovani and Targets Ribonucleotide Reductase to Exert Leishmanicidal Activity","volume":"61","author":"Sen","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Mohajeri, M., Saghaei, L., Ghanadian, M., Saberi, S., Pestechian, N., and Ostadhusseini, E. (2018). Synthesis and In Vitro Leishmanicidal Activities of Six Quercetin Derivatives. Adv. Biomed. Res., 7.","DOI":"10.4103\/abr.abr_76_17"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1021\/acs.molpharmaceut.2c00492","article-title":"Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis: In Vitro\/Ex Vivo Studies and Mechanistic Insights","volume":"19","author":"Das","year":"2022","journal-title":"Mol. Pharm."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0014-4894(85)90047-5","article-title":"Leishmania Donovani: Amastigote Inhibition and Mode of Actior of Berberine","volume":"60","author":"Ghosh","year":"1985","journal-title":"Exp. Parasitol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Calvo, A., Moreno, E., Larrea, E., Sanmart\u00edn, C., Irache, J.M., and Espuelas, S. (2020). Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB\/c Mice. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090858"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03402104","article-title":"Dihydrobetulinic Acid Induces Apoptosis in Leishmania donovani by Targeting DNA Topoisomerase I and II: Implications in Antileishmanial Therapy","volume":"9","author":"Chowdhury","year":"2003","journal-title":"Mol. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ja.2010.2","article-title":"Anti-Leishmanial Activity of Betulin Derivatives","volume":"63","author":"Alakurtti","year":"2010","journal-title":"J. Antibiot."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Youssefi, M.R., Moghaddas, E., Tabari, M.A., Moghadamnia, A.A., Hosseini, S.M., Farash, B.R.H., Ebrahimi, M.A., Mousavi, N.N., Fata, A., and Maggi, F. (2019). In Vitro and In Vivo Effectiveness of Carvacrol, Thymol and Linalool against Leishmania infantum. Molecules, 24.","DOI":"10.3390\/molecules24112072"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.biopha.2009.02.004","article-title":"Inhibitory Activity of Limonene against Leishmania Parasites in Vitro and in Vivo","volume":"63","author":"Arruda","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Sosa, A.M., Moya \u00c1lvarez, A., Bracamonte, E., Korenaga, M., Marco, J.D., and Barroso, P.A. (2020). Efficacy of Topical Treatment with (\u2212)-Epigallocatechin Gallate, A Green Tea Catechin, in Mice with Cutaneous Leishmaniasis. Molecules, 25.","DOI":"10.3390\/molecules25071741"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3109\/14756366.2015.1088841","article-title":"Exploring the Inhibitory Activity of Withaferin-A against Pteridine Reductase-1 of L. Donovani","volume":"31","author":"Chandrasekaran","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02349.x","article-title":"Evaluation of CO2 Laser Efficacy in the Treatment of Cutaneous Leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/plm-2015-0008","article-title":"Evaluation of CO2 Laser Efficacy in the Treatment of Cutaneous Leishmaniasis in a Group of 10 Sudanese Patients","volume":"4","author":"Osman","year":"2015","journal-title":"Photonics Lasers Med."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Valencia, B.M., Miller, D., Witzig, R.S., Boggild, A.K., and Llanos-Cuentas, A. (2013). Novel Low-Cost Thermotherapy for Cutaneous Leishmaniasis in Peru. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002196"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/jrms.JRMS_934_19","article-title":"Heat Therapy for Cutaneous Leishmaniasis: A Literature Review","volume":"26","author":"Siadat","year":"2021","journal-title":"J. Res. Med. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Parvez, S., Yadagiri, G., Gedda, M.R., Singh, A., Singh, O.P., Verma, A., Sundar, S., and Mudavath, S.L. (2020). Modified Solid Lipid Nanoparticles Encapsulated with Amphotericin B and Paromomycin: An Effective Oral Combination against Experimental Murine Visceral Leishmaniasis. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-69276-5"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21678707.2024.2335248","article-title":"Current and Emerging Therapies for the Treatment of Leishmaniasis","volume":"12","author":"Sundar","year":"2024","journal-title":"Expert. Opin. Orphan Drugs"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"van Henten, S., Bialfew, F., Hassen, S., Tilahun, F., van Griensven, J., and Abdela, S.G. (2023). Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges. Trop. Med. Infect. Dis., 8.","DOI":"10.1101\/2023.07.05.23292210"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e1177","DOI":"10.1093\/cid\/ciac643","article-title":"Paromomycin and Miltefosine Combination as an Alternative to Treat Patients with Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial","volume":"76","author":"Musa","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing Failure of Miltefosine in the Treatment of Kala-Azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Goyal, V., Mahajan, R., Pandey, K., Singh, S.N., Singh, R.S., Strub-Wourgaft, N., Alves, F., Rabi Das, V.N., Topno, R.K., and Sharma, B. (2018). Field Safety and Effectiveness of New Visceral Leishmaniasis Treatment Regimens within Public Health Facilities in Bihar, India. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006830"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1016\/S1473-3099(23)00353-5","article-title":"The Status of Combination Therapy for Visceral Leishmaniasis: An Updated Review","volume":"24","author":"Dorlo","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S1473-3099(15)00243-1","article-title":"Old and New Challenges in Chagas Disease","volume":"15","author":"Perez","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"100946","DOI":"10.1016\/j.lanmic.2024.07.009","article-title":"Climate Change and Trypanosoma cruzi Transmission in North and Central America","volume":"5","author":"Forsyth","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Lewis, M.D., Francisco, A.F., Jayawardhana, S., Langston, H., Taylor, M.C., and Kelly, J.M. (2018). Imaging the Development of Chronic Chagas Disease after Oral Transmission. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-29564-7"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e13429","DOI":"10.1111\/tid.13429","article-title":"American Trypanosomiasis (Chagas Disease) in Solid Organ Transplantation","volume":"22","author":"Radisic","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1471-0528.12396","article-title":"Frequency of the Congenital Transmission of Trypanosoma cruzi: A Systematic Review and Meta-Analysis","volume":"121","author":"Howard","year":"2014","journal-title":"BJOG"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"da Gama, A.N.S., and Soeiro, M.d.N.C. (2025). Trypanosoma cruzi Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks. Pathogens, 14.","DOI":"10.3390\/pathogens14020133"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13071-019-3541-5","article-title":"Heterogeneity of Trypanosoma cruzi Infection Rates in Vectors and Animal Reservoirs in Colombia: A Systematic Review and Meta-Analysis","volume":"12","year":"2019","journal-title":"Parasit. Vectors"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/tmi.12002","article-title":"Myocardial Scars Correlate with Eletrocardiographic Changes in Chronic Trypanosoma cruzi Infection for Dogs Treated with Benznidazole","volume":"18","author":"Caldas","year":"2013","journal-title":"Trop. Med. Int. Health"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vetpar.2015.11.016","article-title":"Chagas Disease in a Texan Horse with Neurologic Deficits","volume":"216","author":"Bryan","year":"2016","journal-title":"Vet. Parasitol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13071-022-05190-1","article-title":"A Review on the Diagnosis of Animal Trypanosomoses","volume":"15","author":"Desquesnes","year":"2022","journal-title":"Parasit. Vectors"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A Mechanism for Cross-Resistance to Nifurtimox and Benznidazole in Trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF01941187","article-title":"Interaction of Benznidazole Reactive Metabolites with Nuclear and Kinetoplastic DNA, Proteins and Lipids from Trypanosoma cruzi","volume":"44","author":"Castro","year":"1988","journal-title":"Experientia"},{"key":"ref_160","first-page":"e20230787","article-title":"Causality and Severity of Adverse Reactions and Biochemical Changes to Benznidazole Treatment in Patients with Chronic Chagas Disease","volume":"121","author":"Belmino","year":"2024","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2010.11.010","article-title":"Genome-Wide RNAi Screens in African Trypanosomes Identify the Nifurtimox Activator NTR and the Eflornithine Transporter AAT6","volume":"176","author":"Baker","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"115104","DOI":"10.1016\/j.taap.2020.115104","article-title":"Nitrofuran Drugs beyond Redox Cycling: Evidence of Nitroreduction-Independent Cytotoxicity Mechanism","volume":"401","author":"Cho","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1756-3305-4-169","article-title":"Gene Expression Study Using Real-Time PCR Identifies an NTR Gene as a Major Marker of Resistance to Benznidazole in Trypanosoma cruzi","volume":"4","author":"Palacio","year":"2011","journal-title":"Parasit. Vectors"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0020-7519(99)00168-X","article-title":"Identification of Six Trypanosoma Cruzi Phylogenetic Lineages by Random Amplified Polymorphic DNA and Multilocus Enzyme Electrophoresis","volume":"30","author":"Brisse","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Vela, A., Coral-Almeida, M., Sereno, D., Costales, J.A., Barnab\u00e9, C., and Breni\u00e8re, S.F. (2021). In Vitro Susceptibility of Trypanosoma cruzi Discrete Typing Units (Dtus) to Benznidazole: A Systematic Review and Meta-Analysis. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009269"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1590\/S0036-46651996000100007","article-title":"Etiological Drug Treatment of Human Infection by Trypanosoma cruzi","volume":"38","author":"Levi","year":"1996","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"107264","DOI":"10.1016\/j.actatropica.2024.107264","article-title":"Tackling the Challenges of Human Chagas Disease: A Comprehensive Review of Treatment Strategies in the Chronic Phase and Emerging Therapeutic Approaches","volume":"256","author":"Ramos","year":"2024","journal-title":"Acta Trop."},{"key":"ref_169","first-page":"CD003463","article-title":"Trypanocidal Drugs for Chronic Asymptomatic Trypanosoma cruzi Infection","volume":"2014","author":"Villar","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Ribeiro, I., Sevcsik, A.-M., Alves, F., Diap, G., Don, R., Harhay, M.O., Chang, S., and Pecoul, B. (2009). New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients. PLoS Negl. Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000484"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Bahia, M.T., de Andrade, I.M., Martins, T.A.F., Nascimento, \u00c1.F.d.S.d., Diniz, L.d.F., Caldas, I.S., Talvani, A., Trunz, B.B., Torreele, E., and Ribeiro, I. (2012). Fexinidazole: A Potential New Drug Candidate for Chagas Disease. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001870"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(23)00651-5","article-title":"Efficacy and Safety of Fexinidazole for Treatment of Chronic Indeterminate Chagas Disease (FEXI-12): A Multicentre, Randomised, Double-Blind, Phase 2 Trial","volume":"24","author":"Pinazo","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol Biosynthesis and Drug Development for Chagas Disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.47.1.223-230.2003","article-title":"Chemotherapy with Benznidazole and Itraconazole for Mice Infected with Different Trypanosoma cruzi Clonal Genotypes","volume":"47","author":"Bahia","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas Disease Drug Discovery: Toward a New Era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. cruzi Carriers: The STOP-CHAGAS Trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"100972","DOI":"10.1016\/j.lanmic.2024.100972","article-title":"Challenges and Advancements in the Development of Vaccines and Therapies against Chagas Disease","volume":"5","author":"Pinazo","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1073\/pnas.1807915115","article-title":"Clinical and Veterinary Trypanocidal Benzoxaboroles Target CPSF3","volume":"115","author":"Wall","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41564-022-01211-y","article-title":"Discovery of an Orally Active Benzoxaborole Prodrug Effective in the Treatment of Chagas Disease in Non-Human Primates","volume":"7","author":"Padilla","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1016\/S1473-3099(23)00358-4","article-title":"Second stage human African Trypanosomiasis with Trypanosoma brucei rhodesiense treated with fexinidazole","volume":"23","author":"Helleberg","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_181","unstructured":"Drugs for Neglected Diseases initiative (DNDi) (2025, August 07). DNDI-6148 Chagas Disease. Available online: https:\/\/dndi.org\/research-development\/portfolio\/dndi-6148-chagas\/."},{"key":"ref_182","unstructured":"(2025, September 03). DNDi Chagas Disease: UW Series. Available online: https:\/\/dndi.org\/research-development\/portfolio\/uw-series\/."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"eadg8105","DOI":"10.1126\/scitranslmed.adg8105","article-title":"Short-Course Combination Treatment for Experimental Chronic Chagas Disease","volume":"15","author":"Wall","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Periferakis, A.-T., Periferakis, A., Periferakis, K., Caruntu, A., Anca Badarau, I., Savulescu-Fiedler, I., Scheau, C., and Caruntu, C. (2023). Antimicrobial Properties of Capsaicin: Available Data and Future Research Perspectives. Nutrients, 15.","DOI":"10.3390\/nu15194097"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Valera-Vera, E.A., Reigada, C., Say\u00e9, M., Say\u00e9, S., Digirolamo, F.A., Galceran, F., Miranda, M.R., and Pereira, C.A. (2020). Effect of Capsaicin on the Protozoan Parasite Trypanosoma cruzi. FEMS Microbiol. Lett., 367.","DOI":"10.1093\/femsle\/fnaa194"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12272-014-0481-7","article-title":"Improved Oral Bioavailability of Capsaicin via Liposomal Nanoformulation: Preparation, in Vitro Drug Release and Pharmacokinetics in Rats","volume":"38","author":"Zhu","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Vanrell, M.C., Martinez, S.J., Mu\u00f1oz, L.I., Salassa, B.N., Tudela, J.G., Romano, P.S., Touz, M.C., Pereira De Sa, N., Tudela, G.J., and Romano, P.S. (2022). Induction of Autophagy by Ursolic Acid Promotes the Elimination of Trypanosoma cruzi Amastigotes from Macrophages and Cardiac Cells. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.919096"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.exppara.2013.04.005","article-title":"de In Vivo Activity of Ursolic and Oleanolic Acids during the Acute Phase of Trypanosoma cruzi Infection","volume":"134","author":"Esperandim","year":"2013","journal-title":"Exp. Parasitol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijbiomac.2016.03.014","article-title":"Resveratrol Inhibits Trypanosoma cruzi Arginine Kinase and Exerts a Trypanocidal Activity","volume":"87","author":"Reigada","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Vilar-Pereira, G., Carneiro, V.C., Mata-Santos, H., R Vicentino, A.R., Ramos, I.P., L Giarola, N.L., Feij\u00f3, D.F., Meyer-Fernandes, J.R., Paula-Neto, H.A., and Medei, E. (2016). Resveratrol Reverses Functional Chagas Heart Disease in Mice. Int. J. Biol. Macromol., 12.","DOI":"10.1371\/journal.ppat.1005947"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Barbosa, J.M.C., Nicoletti, C.D., Da Silva, P.B., Melo, T.G., Bora, D., Futuro, O., Ferreira, V.F., and Salom\u00e3oid, K. (2021). Characterization and Trypanocidal Activity of a \u03b2-Lapachone-Containing Drug Carrier. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246811"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpddr.2016.10.003","article-title":"Effects of a Novel \u03b2\u2013Lapachone Derivative on Trypanosoma cruzi: Parasite Death Involving Apoptosis, Autophagy and Necrosis","volume":"6","author":"Fontes","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cvsm.2009.06.004","article-title":"Canine Chagas\u2019 Disease (American Trypanosomiasis) in North America","volume":"39","author":"Barr","year":"2009","journal-title":"Vet. Clin. N. Am.\u2014Small Anim. Pract."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2460\/javma.1991.198.01.132","article-title":"Neurologic Manifestations of Trypanosomiasis in a Dog","volume":"198","author":"Berger","year":"1991","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_195","first-page":"432","article-title":"Natural Reservoir of Trypanosoma cruzi Found in Triatomines Targeting Humans: Results from Nation-Wide Vector Surveillance in El Salvador","volume":"8","author":"Nakagama","year":"2025","journal-title":"JMA J."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Busselman, R.E., Meyers, A.C., Zecca, I.B., Auckland, L.D., Castro, A.H., Dowd, R.E., Curtis-Robles, R., Hodo, C.L., Saunders, A.B., and Hamer, S.A. (2021). High Incidence of Trypanosoma cruzi Infections in Dogs Directly Detected through Longitudinal Tracking at 10 Multi-Dog Kennels, Texas, Usa. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009935"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Dario, M.A., Furtado, C., Lisboa, C.V., de Oliveira, F., Santos, F.M., D\u2019Andrea, P.S., Roque, A.L.R., Xavier, S.C.d.C., and Jansen, A.M. (2022). Trypanosomatid Richness Among Rats, Opossums, and Dogs in the Caatinga Biome, Northeast Brazil, a Former Endemic Area of Chagas Disease. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.851903"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Dur\u00e3es-Oliveira, J., Palma-Marques, J., Moreno, C., Rodrigues, A., Monteiro, M., Alexandre-Pires, G., da Fonseca, I.P., and Santos-Gomes, G. (2024). Chagas Disease: A Silent Threat for Dogs and Humans. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073840"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13071-022-05476-4","article-title":"Technological Advances in the Serological Diagnosis of Chagas Disease in Dogs and Cats: A Systematic Review","volume":"15","author":"Freitas","year":"2022","journal-title":"Parasit. Vectors"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10393-006-0063-3","article-title":"The Role of Ecotones in Emerging Infectious Diseases","volume":"3","author":"Despommier","year":"2006","journal-title":"Ecohealth"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.vetpar.2019.03.005","article-title":"An Oral Dose of Fluralaner Administered to Dogs Kills Pyrethroid-Resistant and Susceptible Chagas Disease Vectors for at Least Four Months","volume":"268","author":"Cardinal","year":"2019","journal-title":"Vet. Parasitol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/mve.12561","article-title":"Control of Pyrethroid-Resistant Populations of Triatoma infestans, the Main Vector of Trypanosoma cruzi, by Treating Dogs with Fluralaner in the Argentine Chaco","volume":"36","author":"Cardinal","year":"2022","journal-title":"Med. Vet. Entomol."},{"key":"ref_203","unstructured":"World Health Organization (2025, August 04). Trypanosomiasis, Human African (Sleeping Sickness), Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness)."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Meisner, J., Kato, A., Lemerani, M.M., Miaka, E.M., Taban, A.I., Wakefield, J., Rowhani-Rahbar, A., Pigott, D.M., Mayer, J.D., and Rabinowitz, P.M. (2022). The Effect of Livestock Density on Trypanosoma brucei gambiense and T. b. rhodesiense: A Causal Inference-Based Approach. PLoS Negl. Trop. Dis., 16.","DOI":"10.1101\/2022.01.13.22268995"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(95)90673-8","article-title":"Risk Factors for Encephalopathy and Mortality during Melarsoprol Treatment of Trypanosoma brucei gambiense Sleeping Sickness","volume":"89","author":"Milord","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug Resistance in African Trypanosomiasis: The Melarsoprol and Pentamidine Story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine Uptake and Resistance in Pathogenic Protozoa: Past, Present and Future","volume":"19","author":"Bray","year":"2003","journal-title":"Trends Parasitol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mib.2016.08.005","article-title":"Exploiting the Achilles\u2019 Heel of Membrane Trafficking in Trypanosomes","volume":"34","author":"Zoltner","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Pertejo, Y., Garc\u00eda-Estrada, C., Mart\u00ednez-Valladares, M., Murugesan, S., Reguera, R.M., and Bala\u00f1a-Fouce, R. (2024). Polyamine Metabolism for Drug Intervention in Trypanosomatids. Pathogens, 13.","DOI":"10.3390\/pathogens13010079"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: M\u00e9decins Sans Fronti\u00e8res Experience in the Democratic Republic of the Congo","volume":"56","author":"Alirol","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Imran, M., Khan, S.A., Alshammari, M.K., Alqahtani, A.M., Alanazi, T.A., Kamal, M., Jawaid, T., Ghoneim, M.M., Alshehri, S., and Shakeel, F. (2022). Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis. Pharmaceuticals, 15.","DOI":"10.3390\/ph15020128"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1473-3099(24)00581-4","article-title":"New WHO Guidelines for Treating Rhodesiense Human African Trypanosomiasis: Expanded Indications for Fexinidazole and Pentamidine","volume":"25","author":"Lindner","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Waithaka, A., and Clayton, C. (2022). Clinically Relevant Benzoxaboroles Inhibit MRNA Processing in Trypanosoma brucei. BMC Res. Notes, 15.","DOI":"10.1186\/s13104-022-06258-y"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Barrett, M.P. (2025). Transforming the Chemotherapy of Human African Trypanosomiasis. Clin. Microbiol. Rev., 38.","DOI":"10.1128\/cmr.00153-23"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The Development of Drugs for Treatment of Sleeping Sickness: A Historical Review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasit. Vectors"},{"key":"ref_216","unstructured":"Food and Agriculture Organization (2025, August 06). Programme Against African Trypanosomosis (PAAT). Available online: https:\/\/www.fao.org\/paat\/the-programme\/the-disease\/en\/."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Akazue, P.I., Ebiloma, G.U., Ajibola, O., Isaac, C., Onyekwelu, K., Ezeh, C.O., and Eze, A.A. (2019). Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal?. Pathogens, 8.","DOI":"10.3390\/pathogens8030135"},{"key":"ref_218","unstructured":"World Health Organization (2021). Ending the Neglect to Attain the Sustainable Development Goals: A Rationale for Continued Investment in Tackling Neglected Tropical Diseases 2021\u20132030."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bmcl.2017.11.028","article-title":"Identification of a 4-Fluorobenzyl L-Valinate Amide Benzoxaborole (AN11736) as a Potential Development Candidate for the Treatment of Animal African Trypanosomiasis (AAT)","volume":"28","author":"Akama","year":"2018","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Giordani, F., Paape, D., Vincent, I.M., Pountain, A.W., Fern\u00e1ndez-Cort\u00e9s, F., Rico, E., Zhang, N., Morrison, L.J., Freund, Y., and Witty, M.J. (2020). Veterinary Trypanocidal Benzoxaboroles Are Peptidase-Activated Prodrugs. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008932"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"14574","DOI":"10.1038\/ncomms14574","article-title":"A Potent Antimalarial Benzoxaborole Targets a Plasmodium falciparum Cleavage and Polyadenylation Specificity Factor Homologue","volume":"8","author":"Sonoiki","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"385","DOI":"10.15252\/emmm.201607370","article-title":"Targeting Toxoplasma Gondii CPSF 3 as a New Approach to Control Toxoplasmosis","volume":"9","author":"Palencia","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1086\/496896","article-title":"Treatment of African Trypanosomiasis with Cordycepin and Adenosine Deaminase Inhibitors in a Mouse Model","volume":"192","author":"Rottenberg","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1021\/jm401530a","article-title":"Structure-Activity Relationships of Synthetic Cordycepin Analogues as Experimental Therapeutics for African Trypanosomiasis","volume":"56","author":"Vodnala","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1038\/s41467-019-13522-6","article-title":"Combining Tubercidin and Cordycepin Scaffolds Results in Highly Active Candidates to Treat Late-Stage Sleeping Sickness","volume":"10","author":"Hulpia","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/361173a0","article-title":"Arsenical-Resistant Trypanosomes Lack an Unusual Adenosine Transporter","volume":"361","author":"Carter","year":"1993","journal-title":"Nature"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0166-6851(99)00206-6","article-title":"Further Evidence for a Link between Melarsoprol Resistance and P2 Transporter Function in African Trypanosomes","volume":"106","author":"MacLeod","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/AAC.48.5.1515-1519.2004","article-title":"The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African Trypanosomes","volume":"48","author":"Anderson","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpddr.2013.01.004","article-title":"Functional Expression of TcoAT1 Reveals It to Be a P1-Type Nucleoside Transporter with No Capacity for Diminazene Uptake","volume":"3","author":"Munday","year":"2013","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Ungogo, M.A., Aldfer, M.M., Natto, M.J., Zhuang, H., Chisholm, R., Walsh, K., McGee, M.C., Ilbeigi, K., Asseri, J.I., and Burchmore, R.J.S. (2023). Cloning and Characterization of Trypanosoma congolense and T. vivax Nucleoside Transporters Reveal the Potential of P1-Type Carriers for the Discovery of Broad-Spectrum Nucleoside-Based Therapeutics against Animal African Trypanosomiasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043144"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Francisco, K.R., Monti, L., Yang, W., Park, H., Liu, L.J., Watkins, K., Amarasinghe, D.K., Nalli, M., Roberto Polaquini, C., and Regasini, L.O. (2023). Structure-Activity Relationship of Dibenzylideneacetone Analogs against the Neglected Disease Pathogen, Trypanosoma brucei. Bioorg. Med. Chem. Lett., 81.","DOI":"10.1016\/j.bmcl.2023.129123"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.2011.05648.x","article-title":"Discovery of Curcumin, a Component of Golden Spice, and Its Miraculous Biological Activities","volume":"39","author":"Gupta","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/mol.114.096016","article-title":"Potent Trypanocidal Curcumin Analogs Bearing a Monoenone Linker Motif Act on Trypanosoma brucei by Forming an Adduct with Trypanothione","volume":"87","author":"Alkhaldi","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Sirak, B., Bizuneh, G.K., Imming, P., and Asres, K. (2024). In Vitro and in Vivo Antitrypanosomal Activity of the Fresh Leaves of Ranunculus Multifidus Forsk and Its Major Compound Anemonin against Trypanosoma congolense Field Isolate. BMC Vet. Res., 20.","DOI":"10.1186\/s12917-023-03856-1"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jep.2017.03.028","article-title":"Bioassay-Guided Isolation of Active Principles from Nigerian Medicinal Plants Identifies New Trypanocides with Low Toxicity and No Cross-Resistance to Diamidines and Arsenicals","volume":"202","author":"Ebiloma","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Ebiloma, G.U., Katsoulis, E., Igoli, J.O., Gray, A.I., and De Koning, H.P. (2018). Multi-Target Mode of Action of a Clerodane-Type Diterpenoid from Polyalthia longifolia Targeting African Trypanosomes. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-22908-3"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.3390\/molecules20057750","article-title":"Anti-Trypanosomal Activity of Nigerian Plants and Their Constituents","volume":"20","author":"Nwodo","year":"2015","journal-title":"Molecules"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Ungogo, M.A., Ebiloma, G.U., Ichoron, N., Igoli, J.O., de Koning, H.P., and Balogun, E.O. (2020). A Review of the Antimalarial, Antitrypanosomal, and Antileishmanial Activities of Natural Compounds Isolated from Nigerian Flora. Front. Chem., 8.","DOI":"10.3389\/fchem.2020.617448"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/vms3.912","article-title":"The Anti- Trypanosoma Activities of Medicinal Plants: A Systematic Review of the Literature","volume":"8","author":"Nekoei","year":"2022","journal-title":"Vet. Med. Sci."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Simone-Finstrom, M.D., and Spivak, M. (2012). Increased Resin. Collection after Parasite Challenge: A Case of Self-Medication in Honey Bees?. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034601"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Mura, A., Pusceddu, M., Theodorou, P., Angioni, A., Floris, I., Paxton, R.J., and Satta, A. (2020). Propolis Consumption Reduces Nosema Ceranae Infection of European Honey Bees (Apis Mellifera). Insects, 11.","DOI":"10.3390\/insects11020124"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Siheri, W., Ebiloma, G.U., Igoli, J.O., Gray, A.I., Biddau, M., Akrachalanont, P., Alenezi, S., Alwashih, M.A., Edrada-Ebel, R., and Muller, S. (2019). Isolation of a Novel Flavanonol and an Alkylresorcinol with Highly Potent Anti-Trypanosomal Activity from Libyan Propolis. Molecules, 24.","DOI":"10.3390\/molecules24061041"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Alenezi, S.S., Alenezi, N.D., Ebiloma, G.U., Natto, M.J., Ungogo, M.A., Igoli, J.O., Ferro, V.A., Gray, A.I., Fearnley, J., and de Koning, H.P. (2022). The Antiprotozoal Activity of Papua New Guinea Propolis and Its Triterpenes. Molecules, 27.","DOI":"10.3390\/molecules27051622"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Alotaibi, A., Ebiloma, G.U., Williams, R., Alenezi, S., Donachie, A.-M., Guillaume, S., Igoli, J.O., Fearnley, J., De Koning, H.P., and Watson, D.G. (2019). European Propolis Is Highly Active against Trypanosomatids Including Crithidia fasciculata. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-47840-y"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Omar, R., Igoli, J.O., Zhang, T., Gray, A.I., Ebiloma, G.U., Clements, C.J., Fearnley, J., Edrada Ebel, R., Paget, T., and de Koning, H.P. (2017). The Chemical Characterization of Nigerian Propolis samples and Their Activity Against Trypanosoma brucei. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-01038-2"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Ebiloma, G.U., Ichoron, N., Siheri, W., Watson, D.G., Igoli, J.O., and De Koning, H.P. (2020). The Strong Anti-Kinetoplastid Properties of Bee Propolis: Composition and Identification of the Active Agents and Their Biochemical Targets. Molecules, 25.","DOI":"10.3390\/molecules25215155"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"e56416","DOI":"10.7554\/eLife.56416","article-title":"Positively Selected Modifications in the Pore of TbAQP2 Allow Pentamidine to Enter Trypanosoma brucei","volume":"9","author":"Alghamdi","year":"2020","journal-title":"eLife"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"taab065","DOI":"10.1093\/jtm\/taab065","article-title":"Efficacy and Safety of Pentamidine Isethionate for Tegumentary and Visceral Human Leishmaniasis: A Systematic Review","volume":"28","author":"Piccica","year":"2021","journal-title":"J. Travel. Med."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/mmi.13854","article-title":"Beyond Immune Escape: A Variant Surface Glycoprotein Causes Suramin Resistance in Trypanosoma brucei","volume":"107","author":"Wiedemar","year":"2018","journal-title":"Mol. Microbiol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.1074\/jbc.RA120.012355","article-title":"Suramin Exposure Alters Cellular Metabolism and Mitochondrial Energy Production in African Trypanosomes","volume":"295","author":"Zoltner","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-Day Melarsoprol Schedule for the Treatment of Late-Stage Human African Trypanosomiasis: Confirmation from a Multinational Study (IMPAMEL II)","volume":"191","author":"Schmid","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/EC.2.5.1003-1008.2003","article-title":"Mechanisms of Arsenical and Diamidine Uptake and Resistance in Trypanosoma brucei","volume":"2","author":"Matovu","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the Treatment of Human African Trypanosomiasis","volume":"90","author":"Burri","year":"2003","journal-title":"Parasitol. Res."},{"key":"ref_254","unstructured":"World Health Organization (2010). Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010."},{"key":"ref_255","first-page":"609","article-title":"A Randomized Clinical Trial of Low Dosage Combination of Pentamidine and Allopurinol in the Treatment of Antimony Unresponsive Cases of Visceral Leishmaniasis","volume":"49","author":"Das","year":"2001","journal-title":"J. Assoc. Physicians India"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2007.76.58","article-title":"Specific Treatment for Trypanosoma cruzi: Lack of Efficacy of Allopurinol in the Human Chronic Phase of Chagas Disease","volume":"76","author":"Rassi","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"e02264-18","DOI":"10.1128\/AAC.02264-18","article-title":"Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi","volume":"63","author":"Mazzeti","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vetpar.2018.01.012","article-title":"Feline Leishmaniosis: Is the Cat a Small Dog?","volume":"251","author":"Pennisi","year":"2018","journal-title":"Vet. Parasitol."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Dorn, P.L., Monroy, M.C., and Stevens, L. (2022). Sustainable, Integrated Control of Native Vectors: The Case of Chagas Disease in Central America. Front. Trop. Dis., 3.","DOI":"10.3389\/fitd.2022.971000"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-4758(00)01827-5","article-title":"African Bovine Trypanosomiasis: The Problem of Drug Resistance","volume":"17","author":"Geerts","year":"2001","journal-title":"Parasitol. Today"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vetpar.2009.01.018","article-title":"Control of Bovine Trypanosomosis by Restricted Application of Insecticides to Cattle Using Footbaths","volume":"161","author":"Bouyer","year":"2009","journal-title":"Vet. Parasitol."},{"key":"ref_262","unstructured":"Feldmann, U., and Hendrichs, J. (2001). Integrating the Sterile Insect Technique as a Key Component of Area-Wide Tsetse and Trypanosomiasis Intervention, Food and Agriculture Organization of the United Nations (FAO)."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Lord, J.S., Lea, R.S., Allan, F.K., Byamungu, M., Hall, D.R., Lingley, J., Mramba, F., Paxton, E., Vale, G.A., and Hargrove, J.W. (2020). Assessing the Effect of Insecticide-Treated Cattle on Tsetse Abundance and Trypanosome Transmission at the Wildlife-Livestock Interface in Serengeti, Tanzania. PLoS Negl. Trop. Dis., 14.","DOI":"10.1101\/2020.04.14.040873"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-4758(97)01170-8","article-title":"Trypanosomiasis and Tsetse Control with Insecticidal Pour-Ons\u2014Fact and Fiction?","volume":"14","author":"Baylis","year":"1998","journal-title":"Parasitol. Today"},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Gimonneau, G., Alioum, Y., Abdoulmoumini, M., Zoli, A., Cene, B., Adakal, H., and Bouyer, J. (2016). Insecticide and Repellent Mixture Pour-On Protects Cattle against Animal Trypanosomosis. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0005248"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2915.2006.00648.x","article-title":"Footbath Acaricide Treatment to Control Cattle Infestation by the Tick Amblyomma variegatum","volume":"20","author":"STACHURSKI","year":"2006","journal-title":"Med. Vet. Entomol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S0074-02762007005000092","article-title":"Southern Cone Initiative for the Elimination of Domestic Populations of Triatoma Infestans and the Interruption of Transfusional Chagas Disease. Historical Aspects, Present Situation, and Perspectives","volume":"102","author":"Dias","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40249-015-0092-7","article-title":"Preventing the Transmission of American Trypanosomiasis and Its Spread into Non-Endemic Countries","volume":"4","author":"Liu","year":"2015","journal-title":"Infect. Dis. Poverty"},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Timm, B.L., da Gama, A.N.S., Batista, M.M., Batista, D.d.G.J., Boykin, D.W., De Koning, H.P., and Correia Soeiro, M.d.N. (2023). Arylimidamides Have Potential for Chemoprophylaxis Against Blood-Transmitted Chagas Disease. Pathogens, 12.","DOI":"10.3390\/pathogens12050701"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"e210130chgsa","DOI":"10.1590\/0074-02760210130chgsa","article-title":"Subregional Initiatives for Chagas Disease. A Path of Technical Cooperation, Opened by the Countries, as an Approach to a Neglected Disease","volume":"117","author":"Lima","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60147-5","article-title":"The Southern Cone Initiative against Chagas Disease","volume":"42","author":"Schofield","year":"1999","journal-title":"Adv. Parasitol."},{"key":"ref_272","first-page":"e210130","article-title":"Chagas Disease Control-Surveillance in the Americas: The Multinational Initiatives and the Practical Impossibility of Interrupting Vector-Borne Trypanosoma cruzi Transmission","volume":"116","author":"Monroy","year":"2021","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Reid, E., Deb, R.M., Ali, A., Singh, R.P., Mishra, P.K., Shepherd, J., Singh, A.M., Bharti, A., Singh, C., and Sharma, S. (2023). Molecular Surveillance of Insecticide Resistance in Phlebotomus Argentipes Targeted by Indoor Residual Spraying for Visceral Leishmaniasis Elimination in India. PLoS Negl. Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011734"},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Jha, T.K. (2017). Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries. Kala Azar in South Asia: Current Status and Sustainable Challenges, Springer. [2nd ed.].","DOI":"10.1007\/978-3-319-47101-3_4"},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Denton-Schneider, J.M.E. (2025). Disease, Disparities, and Development: Evidence from Chagas Disease Control in Brazil, National Bureau of Economic Research, Inc.. NBER Working Paper.","DOI":"10.3386\/w33518"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"e1763","DOI":"10.1016\/S2214-109X(21)00392-2","article-title":"Towards the Elimination of Visceral Leishmaniasis as a Public Health Problem in East Africa: Reflections on an Enhanced Control Strategy and a Call for Action","volume":"9","author":"Alvar","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Makau-Barasa, L.K., Ochol, D., Yotebieng, K.A., Adera, C.B., and de Souza, D.K. (2022). Moving from Control to Elimination of Visceral Leishmaniasis in East Africa. Front. Trop. Dis., 3.","DOI":"10.3389\/fitd.2022.965609"},{"key":"ref_278","unstructured":"World Health Organization (2024). Developing a Strategic Plan for the Elimination of Visceral Leishmaniasis in Eastern Africa: Report of a Stakeholder Meeting, Nairobi, Kenya, 24\u201327 January 2023."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13071-015-0925-z","article-title":"A Narrative Review of Visceral Leishmaniasis in Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, the Crimean Peninsula and Southern Russia","volume":"8","author":"Strelkova","year":"2015","journal-title":"Parasit. Vectors"},{"key":"ref_280","first-page":"342","article-title":"Epidemiology and Control of Leishmaniasis in the Former USSR: A Review Article","volume":"13","author":"Sergiev","year":"2018","journal-title":"Iran. J. Parasitol."},{"key":"ref_281","first-page":"323","article-title":"Eradication of Leishmaniasis in the USSR during the 7-Year-Plan","volume":"28","author":"Isaev","year":"1959","journal-title":"Med. Parazitol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13071-016-1558-6","article-title":"Seroepidemiology and Molecular Diversity of Leishmania donovani Complex in Georgia","volume":"9","author":"Babuadze","year":"2016","journal-title":"Parasit. Vectors"},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Alvar, J., V\u00e9lez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., and de Boer, M. (2012). Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035671"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/zph.12977","article-title":"The Current Epidemiology of Leishmaniasis in Turkey, Azerbaijan and Georgia and Implications for Disease Emergence in European Countries","volume":"69","author":"Jumakanova","year":"2022","journal-title":"Zoonoses Public Health"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40262-023-01216-8","article-title":"Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study","volume":"62","author":"Tarral","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/mtsp.mtsp_15_23","article-title":"Environmental Impact of Pharmaceuticals: A Comprehensive Review","volume":"7","author":"Ashiwaju","year":"2023","journal-title":"Matrix Sci. Pharma"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"207","DOI":"10.12688\/openreseurope.18008.1","article-title":"Environmental Impacts of Drugs against Parasitic Vector-Borne Diseases and the Need to Integrate Sustainability into Their Development and Use","volume":"4","author":"Lima","year":"2024","journal-title":"Open Res. Eur."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1021\/acsinfecdis.4c00131","article-title":"Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection","volume":"10","author":"Ilbeigi","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_289","unstructured":"World Health Organization (2025, August 05). The One Health Approach and Key Recommendations of the Quadripartite, Available online: https:\/\/www.who.int\/publications\/m\/item\/the-one-health-approach-and-key-recommendations-of-the-quadripartite."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/acs.molpharmaceut.3c00844","article-title":"Clinical and Preclinical Methods of Heat-Stabilization of Human Vaccines","volume":"21","author":"Williamson","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_291","unstructured":"World Health Organization (2022). One Health Joint Plan of Action (2022\u20132026): Working Together for the Health of Humans, Animals, Plants and the Environment."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.glohj.2024.08.004","article-title":"Building a Transdisciplinary Science of One Health with a Global Vision","volume":"8","author":"Zhou","year":"2024","journal-title":"Glob. Health J."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"2377259","DOI":"10.1080\/17441692.2024.2377259","article-title":"Analyzing One Health Governance and Implementation Challenges in Mexico","volume":"19","author":"Dreser","year":"2024","journal-title":"Glob. Public Health"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1415\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:10Z","timestamp":1760035570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":293,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ph18091415"],"URL":"https:\/\/doi.org\/10.3390\/ph18091415","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}